Breast Cancer Risk Articles & Analysis
27 news found
Developed by specialists from the medical, technology, and design fields, the platform aims to establish a culture of preventative healthcare in Latvia as well as educate women on breast cancer risks and contraception methods. By educating more individuals and collecting real-world data, skrinings.lv is actively contributing to decreasing ...
Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by endocrine therapy in breast cancer patients Elinzanetant is an innovative non-hormonal development compound in development for the treatment of vasomotor symptoms during menopause Bayer, a global leader in women’s healthcare, announced today that ...
ByBayer AG
Women are increasingly aware of the cancer risk associated with breast density. QVCAD Invenia ABUS combination provides a solution that has the potential to be the preferred screening method for women with dense breast parenchyma. ...
The FGS imaging system may help reduce the risk of two breast cancer-related morbidities, lymphedema and tissue necrosis. This advanced capability of intraoperative imaging could improve the health and quality of life for breast cancer survivors. About OnLume Inc.: Based in Madison, Wisconsin, OnLume is a ...
Launched by Longenesis and other regional healthcare stakeholders in 2020, Skrinings.lv is an online health platform that helps individuals better understand their reproductive and breast health. Unsuitable or incorrectly used methods of contraception result in around 33 million unintended pregnancies each year. ...
Scientific Presentation: Cryoablation of Low-Risk Breast Cancer An Update of the ICE3 Trial Dr. Kenneth R. Tomkovich, Co-Primary Investigator of the ICE3 trial, presented promising interim data on cryoablation of small, low-risk breast cancers on April 26. ...
Results were impressive: a total of 86.8% screen-detected and 44.9% of interval cancers received a Transpara score of 10, the category with the highest risk for breast cancer. By extending the highest risk group to 20% of the population, 93% of the screen-detected and 63% of the interval cancers ...
One of the most significant components of the results was the risk-adjusted analysis. When looking at key risk factors for BCRL, including body weight, stage of cancer, type of cancer surgery, lymph node dissection, chemotherapy, and radiation, the benefit of using L-Dex monitoring was consistent and showed the utility of L-Dex ...
"Given the increasing demand for the product and with the pressure on radiologists and the increasing incidence of breast cancer worldwide, it is vital we make optimal use of this new technology to find cancers faster and earlier, especially the most aggressive ones, so that survival rates improve," he said. "With the growing shortage of ...
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced the publication of SweDCIS randomized clinical trial data in the Special Issue: Updates on Breast Cancer edition of Cancers. The randomized study demonstrates that the DCISionRT test ...
Kheiron Medical Technologies, an award-winning applied science company based in the United Kingdom, has launched RSViP™, a new artificial intelligence-enabled tool that helps breast screening programs optimize scheduling for women who are at risk for potentially developing breast cancer. ...
Invenia ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. ...
(NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that a peer reviewed article titled, “VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot ...
QView Medical is the only FDA AI Ultrasound Technology approved for breast screening. But now, we are moving beyond the clinical suite. QView is joining women in the initiative around Breast Cancer with the launch of AmIDense.com and the supporting #AmIDense. Let's START the conversation around Breast Density. The 2021 American ...
(NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that the first peer reviewed article “Cryoablation Without Excision for Low-Risk, Early-Stage Breast Cancer: 3-Year Interim Analysis ...
With the help of LU DF LAB, VITA female oncology patient association, Semper Anticus we are launching Skrinings.lv in Latvia - a digital platform for breast cancer pre-screening, associated risk calculation, and community proactive involvement in research initiatives. Skrinigs.lv is a web platform, available in 3 languages (Latvian, English, ...
Longenesis joins the 500 Startups family in a 16-week Singapore-based program designed to accelerate the growth of the best-selected startups through deep market insights, hands-on coaching and exposure to 500’s network of partners, experts, and talent. For the next 4 months, our team will be fully immersed in the Singapore market leveraging the 500 Startups’ network to multiply the ...
“Medicine is great, but surgery is actually where I feel the most comfortable,” the physician shared. “And I found out that breast cancer is one of those professions where you actually cure people. ...
Making It Personal Earlier this fall, Seno Medical recognized that several of its employees have been touched by breast cancer, but others have not. In an effort to raise awareness of what a patient goes through when undergoing a breast exam and having a suspicious mass identified, Seno launched an employee initiative, termed “Making It ...
A review of the scientific literature on women workers and breast cancer, released by the US Breast Cancer Fund, uncovered more than 20 occupations associated with increased risk of breast cancer compared to the risk for the general population. With the release ...